Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors-Reference-Cited by-同舟云学术

Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors

Published:2010-06 Issue:6 Volume:21 Page:704-712
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Boutin Sylvie¹,Monteilhet Virginie¹,Veron Philippe¹,Leborgne Christian¹,Benveniste Olivier²,Montus Marie Françoise¹,Masurier Carole¹

Affiliation:

1. Laboratoire d'Immunologie, Genethon, 91002 Evry Cedex, France.

2. Faculté de Médecine Pierre et Marie Curie, Hôpital Pitié-Salpêtrière, Assistance Publique Hôpitaux de Paris, 75013 Paris, France.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2009.182

Reference61 articles.

1. Recombinant AAV Viral Vectors Pseudotyped with Viral Capsids from Serotypes 1, 2, and 5 Display Differential Efficiency and Cell Tropism after Delivery to Different Regions of the Central Nervous System

2. Worldwide Epidemiology of Neutralizing Antibodies to Adeno‐Associated Viruses

3. Cloning and Characterization of Adeno-Associated Virus Type 5

Cited by 734 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene therapy vector-related myocarditis;International Journal of Cardiology;2024-03

2. Repeated AAV9 Titer Determination in a Presymptomatic SMA Patient with Three SMN2 Gene Copies – A Case Report;Journal of Neuromuscular Diseases;2024-02-01

3. AAV mediated gene therapy for haemophilia B: From the early attempts to modern trials;Thrombosis Research;2024-02

4. Optimal trade-off control in machine learning–based library design, with application to adeno-associated virus (AAV) for gene therapy;Science Advances;2024-01-26

5. Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma;Virology Journal;2024-01-12